Erlangen Germany
Biographical Sketch: Graduate Studies
1984-1990
Studies in Human Medicine, Universität Marburg
1990
Thesis Universität Mainz („magna cum laude“)
1998
Habilitation Universität Mainz
Scientific Career
1990-1992
Resident in Internal Medicine
I. Medizinische Klinik und Poliklinik der Universität Mainz
1992-1995
DFG-Grant Mucosal Immunology Section (Prof. Warren Strober) National Institute of Health, Bethesda, USA
1995-1997
Fellow in Gastroenterology
I. Medizinische Klinik und Poliklinik der Universität Mainz
1997
Diplomate, Board of Internal Medicine
1998
Assistant Professor of Internal Medicine
Senior Physician
I. Medizinische Klinik und Poliklinik der Universität Mainz
1999
Diplomate, Board of Gastroenterology
1999
Visiting professor at the Harvard Medical School in Boston, Brigham and Women’s Hospital, USA
2001
C3-Professorship for Molecular Gastroenterology I. Medizinische Klinik und Poliklinik der Universität Mainz
2003
Head of Endoscopy
I. Medizinische Klinik und Poliklinik der Universität Mainz
2007
W3-Professorship Universität Mainz
Director Institute of Molecular Medicine
Co-Director I. Medizinische Klinik und Poliklinik der Universität Mainz
2009
W3-Professorship Internal Medicine I
Friedrich-Alexander-Universität Erlangen-Nürnberg
Head of Department Medizinische Klinik 1 Universitätsklinikum Erlangen
Awards and Honors
1992-1996
DFG Grants and Fogarty International Center Scholarship (NIH)
1995
International Scholarship of the Clinical Immunology Society
1995
Young Investigator Award, North American Society for Pediatric Gastroenterology and Nutrition
1997
Gerhard-Hess-Preis der Deutschen Forschungsgemeinschaft
1999
Frerichs-Preis, Deutsche Gesellschaft für Innere Medizin
2000
Thannhauser-Preis, Deutsche Gesellschaft für Gastroenterologie
2000
Fulbright Scholarship for Senior Scientists
2005
Dr. Norbert Henning-Preis, Universität Erlangen-Nürnberg
2006
Ernst Jung-Preis für Medizinische Forschung (Jung-Stiftung)
2008
United European Gastroenterology Foundation Prize (UEGF Research Prize)
Any personal financial relationships? Yes
| Organization Name | Relationship |
|---|---|
| Pentax Europe GmbH | 1 |
| Giuliani Pharma SpA | 1 |
| MSD Sharp & Dohme GmbH | 1 |
| Index Pharmaceuticals AB | 1 |
| German Research Foundation | 6 |
| Falk Foundation GmbH | 3 |
| AbbVie GmbH & Co. KG | 3 |
 |
I have disclosed to ICMI all relevant financial relationships, and hereby allow ICMI to disclose this information to learners in print. |
|
To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias. |
|
1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity. |
|
2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA). |
|
3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products. |
|
4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature". |
T Cell Subsets in IBD
OR.92 Gut Peri-Cryptal Fibroblasts Re-Program Intestinal Stem Cells via Interleukin-33
T.82 Type-III IFN signalling through PKR is required for RipK3 activation in intestinal epithelial cells.
T.105 Role of SMAD7 in the intestinal epithelium for gut homeostasis and tumor development
W.41 Cell Shedding Arrested in the Absence of GGTase-Prenylation Within IECs
W.112 A single viral caspase-8 inhibitor is able to disrupt intestinal immune homeostasis in vivo
W.114 The role of epithelial caspase-8 during infection with Salmonella typhimurium